Committee Unblinds Phase III Zytiga Study
USPSTF and ACS Recommend Less Frequent Cervical Cancer Screenings and Pap Smears
Tobacco Control and Prevention Saved 795,000 Lives Between 1975-2000, Study Shows
Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005
Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit
Study: Freezing Secondary Tumors Helpful in Metastatic Breast Cancer
Women Who Received CMF Chemotherapy Score Lower On Cognitive Skill Exams
Three Studies Demonstrate Oncotype DX Test Effectiveness
ACG Highlights Link Between Obesity and Colorectal Cancer
Olaparib Study Demonstrates No Changes In Overall Survival
Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study
Trials Approved by NCI CTEP For the Month of March
Trending Stories
- Imaging’s ride to the bottom in clinical trials—and why it matters now
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - In the Headlines: Is oncology ready to move away from animal testing?
- NIH says it’s moving away from animal-based models
- The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic - ODAC nixes GSK’s Blenrep myeloma regimens, citing ocular toxicity, dosing, applicability to U.S. population
